Antibodies of the IgG4—but not the IgG1 ... in the presence of erythrocytes or an erythrocyte-derived small molecule, as well as under reducing conditions. Making the IgG1 core hinge more ...

including antibody–drug conjugates (ADCs) and small molecule–drug conjugates (SMDCs), each tailored to address the specific biology of the cancer (Fig. 1). The company is seeking partnerships ...

BenevolentAI has entered a two-year agreement with the MRC Technology to investigate new small molecule and antibody drug candidates. The UK-based artificial intelligence company has teamed up ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Moreover, the number of players is likely to be significantly less than in the small molecule AI space, considering the complexity of building AI models for intricate molecules like antibodies.

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has entered into an exclusive licensing agreement with Biosion, Inc., ...

Aclaris Therapeutics has secured an exclusive licence from Biosion for the global rights to two new antibodies, BSI-045B and ...